Back to Agenda
Session 6: Hot Topics And Bitesized Updates
Session Chair(s)
Maarten Lagendijk, MSC
Deputy EU QPPV
MSD, Netherlands
The Hot Topics session provides insights in the very latest on discussions in specific Safety areas of interest. The expert speakers that lead these discussions will share information on these key topics, the issues at hand, the progress that is being made and what the audience can expect on these topics for the future. The topics will be of interest to a broad audience and will be of specific value to participants that are not able to attend Industry Association meetings or public meetings with EMA due to limited attendance possibilities.
Speaker(s)
Willemijn van der Spuij, MSC
Bristol Myers Squibb, Switzerland
Executive Director Europe | International - Patient Safety
Module XVI – What is the impact?
Peter De Veene, MD
MSD Belgium, Belgium
QPPV
Windsor Framework Update - Recap and Feedback from the UK National QPPV Forum
Claire Longman, MSC
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Pharmacovigilance Inspector
Upcoming EFPIA PVEG interactions with EMA
Magnus Ysander, MD
AstraZeneca, Sweden
EU & UK QPPV & Head Pharmacovigilance Excellence
Windsor Framework Update - Recap and Feedback from the UK National QPPV Forum
Elspeth McIntosh, MBA, RN
Castle Pharmacovigilance Ltd, United Kingdom
Director
Vicki Edwards, RPH
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
Have an account?